Literature DB >> 16047476

HTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa.

J Y Barclay1, A G Morris, C U Nwokolo.   

Abstract

The extent to which human telomerase reverse transcriptase (hTERT) mRNA and its splice variants control telomerase activity in human cancers is controversial. Telomerase and hTERT mRNA were assessed quantitatively in paired samples of gastric adenocarcinoma and adjacent normal tissue. Splice variants within the hTERT reverse transcriptase domain (alpha, beta, alphabeta) were detected by RT-PCR. In gastric adenocarcinoma, compared to normal tissue, median telomerase activity increased significantly (from 0 total product generated [tpg; 95% confidence interval CI, 0-2.3] to 16.1 tpg [95% CI, 3.7-97]; P = 0.008) and median hTERT mRNA levels also increased (from 2.21 [95% CI, 1.40-4.62] to 7.08 [95% CI, 3.26-10.8]; P = 0.0054). hTERT mRNA and telomerase activity correlated in normal gastric mucosa (r = 0.819, P = 0.0002). Alpha, beta, and alphabeta deletions were similar in both groups. We conclude that hTERT mRNA partially regulates telomerase activity in normal gastric mucosa and gastric adenocarcinoma. In contrast, hTERT mRNA splicing is not involved in the regulation of enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047476     DOI: 10.1007/s10620-005-2776-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase.

Authors:  S Kharbanda; V Kumar; S Dhar; P Pandey; C Chen; P Majumder; Z M Yuan; Y Whang; W Strauss; T K Pandita; D Weaver; D Kufe
Journal:  Curr Biol       Date:  2000-05-18       Impact factor: 10.834

2.  Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.

Authors:  T Kanaya; S Kyo; K Hamada; M Takakura; Y Kitagawa; H Harada; M Inoue
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.

Authors:  H S Jong; Y I Park; S Kim; J H Sohn; S H Kang; S H Song; Y J Bang; N K Kim
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

4.  Telomerase activity and patient survival after surgery for gastric and oesophageal cancer.

Authors:  B Usselmann; M Newbold; A G Morris; C U Nwokolo
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 2.566

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Identification of Mad as a repressor of the human telomerase (hTERT) gene.

Authors:  S Oh; Y H Song; J Yim; T K Kim
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

7.  The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.

Authors:  S Oh; Y Song; J Yim; T K Kim
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

8.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.

Authors:  J Nakayama; H Tahara; E Tahara; M Saito; K Ito; H Nakamura; T Nakanishi; E Tahara; T Ide; F Ishikawa
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

9.  Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.

Authors:  Z Wang; S Kyo; M Takakura; M Tanaka; N Yatabe; Y Maida; M Fujiwara; J Hayakawa; M Ohmichi; K Koike; M Inoue
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

10.  Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.

Authors:  W Yasui; H Tahara; E Tahara; J Fujimoto; J Nakayama; F Ishikawa; T Ide; E Tahara
Journal:  Jpn J Cancer Res       Date:  1998-11
View more
  7 in total

1.  Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.

Authors:  Lisa F Lincz; Lisa-Maree Mudge; Fiona E Scorgie; Jennette A Sakoff; Christopher S Hamilton; Michael Seldon
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 2.  Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).

Authors:  Brittany A Avin; Christopher B Umbricht; Martha A Zeiger
Journal:  Int J Oncol       Date:  2016-10-20       Impact factor: 5.650

3.  Telomere lengthening and other functions of telomerase.

Authors:  M P Rubtsova; D P Vasilkova; A N Malyavko; Yu V Naraikina; M I Zvereva; O A Dontsova
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

4.  The regulation of telomerase in oncogenesis.

Authors:  D A Skvortzov; M P Rubzova; M E Zvereva; F L Kiselev; O A Donzova
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

Review 5.  Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.

Authors:  Xuewen Liu; Yuchuan Wang; Guangming Chang; Feng Wang; Fei Wang; Xin Geng
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

6.  Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells.

Authors:  Mohsen Khosravi-Maharlooei; Mansooreh Jaberipour; Ahmad Hosseini Tashnizi; Armin Attar; Fatemeh Amirmoezi; Mojtaba Habibagahi
Journal:  Int J Mol Cell Med       Date:  2015

Review 7.  Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.

Authors:  Anna A Plyasova; Dmitry D Zhdanov
Journal:  Biomedicines       Date:  2021-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.